Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial
Journal of the European Academy of Dermatology and Venereology | Jul 19, 2019
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients
Journal of the American Academy of Dermatology | Jul 18, 2019
Atopic dermatitis shows significant cutaneous comorbidity: Results from large-scale investigations in the working population
Journal of the European Academy of Dermatology and Venereology | Jul 18, 2019
Brodalumab for the treatment of moderate-to-severe psoriasis: Case series and literature review
Clinical, Cosmetic and Investigational Dermatology | Jul 17, 2019
Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis
European Journal of Gastroenterology & Hepatology | Jul 15, 2019
Risk of malignancy in patients with psoriasis: A 15-year nationwide population-based prospective cohort study in Korea
Journal of the European Academy of Dermatology and Venereology | Jul 13, 2019
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial
Journal of the American Academy of Dermatology | Jul 08, 2019